Kana wanga uchifunga nezvemishonga yeGLP-1 yekuderedza muviri asi wakatadza nekuda kwemitengo, 2026 inoita seinosiyana nezvazvaiita gore kana maviri apfuura.

Mimwe mishonga yeGLP-1 yemhando dzakasiyana-siyana parizvino iripo kuburikidza nezvirongwa zvevagadziri zvekuzvipa mari pachavo nemitengo yakaderera yakabudiswa yemari chaiyo kupfuura kare. Zvimwe zvigadzirwa zvemahara zviri mumiriyoni zvakare zvave pamusika, zvichipa varwere zvimwe zvakawanda pazvimiro zvakasiyana zvemari. Kuvharwa kweinishuwarenzi kuchiri kusashanda zvakaenzana, asi zvimwe zvitsva zveMedicare nechirongwa chekuchengetedza mari chevagadziri vari kuchinja zvimwe varwere vanobhadhara.

Hezvino zvinhu zviri pamusoro pemari yemishonga yeGLP-1 mu2026, zviri kuchinja, uye zvinhu zvekutarisa usati wazvisimbisa kuti uchabhadhara mari yakakwana chaiyo.

TL;DR: Zvinokosha Zvekunzwisisa

  • Mimwe mishonga yeGLP-1 yakatenderwa neFDA iripo kuburikidza nezvirongwa zvevagadziri zvekuzvipa mari pachavo nemitengo yakaderera yakabudiswa zvikuru kupfuura mitengo yechinyakare yemari chaiyo.
  • Mahara eWegovy anodhura $149 pamwedzi kune 1.5 mg, $199 kune 4 mg, uye $299 kune 9 mg ne25 mg kuburikidza nechirongwa chekuzvipa mari cheNovoCare.
  • Vazhinji veWegovy vanobaya vanopinda vanogona parizvino kubhadhara $199 pamwedzi kwekutanga kwavo kaviri kwemwedzi mishanu ye0.25 mg kana 0.5 mg kusvika Zvita 31, 2026. Mutengo wekuzvipa mari wakajairika unozova $349 pamwedzi kune mishonga yakanyorwa yekubaya. Wegovy HD i $399 pamwedzi.
  • Foundayo (orforglipron) ine mutengo wekuzvipa mari uchitanga pa $149 pamwedzi kune dzimwe mishonga. Mishonga yakakwirira ine mitengo yakasiyana uye zvimwe zvinodiwa kuti uwane.
  • Medicare GLP-1 Bridge inovapa Medicare Part D vanobatsirwa mukana wekuwana mimwe mishonga yeGLP-1 yekuderedza muviri pa $50 pamwedzi kune chikamu chekubhadhara. Chirongwa chenguva pfupi ichi chiri kubva Chikunguru 1, 2026, kusvika Zvita 31, 2027.
  • Semaglutide yakavhenganiswa haisi yakatenderwa neFDA. FDA yave ichitaura nezve kusagadzikana kwezvinobvisa, zvigadzirwa zvekunyepedzera, matambudziko emhando, uye zvisingafadzi zviri kubva kune zvimwe zvigadzirwa zveGLP-1 zvakavhenganiswa.
  • Kuvharwa kweinishuwarenzi yakazvitsaurira kunosiyana pachirongwa, chinangwa, zvinodiwa zvekutanga zvekutendwa, uye kuti mushonga wekuderedza muviri wakavharirwa here muzvigadzirwa zvebhenefiti.
  • Zvaunobhadhara chaizvo zvinoenderana nemushonga, muyero, kuvharwa kweinishuwarenzi, zvimwe zvigadzirwa, uye kana uchikwanisa kune chimwe chipo.

Wemubvunzo nezvemishonga yeGLP-1, mitengo, kana kuvharwa? Buka kushanya kwe $39 paunzi neAugust AI. Chiremba ane rezinesi muUS anogona kuongorora nhoroondo yako yehutano uye kukurukura kana mushonga weGLP-1 wakakodzera kwauri, uine mushonga unogona kuendeswa kuchipatara musi mumwechete munyika dzese 50 apo zvakakodzera kune hutano.

Kushanya uku hakusi kuvimbisa mushonga. Kureba kwemwedzi weGLP-1 yekuderedza muviri kunowanzobatsirwa zviri nani nevamwe vanopa hutano kana endocrinologist anogona kutarisa kufambira mberi, kugadzirisa muyero, uye kugaradzira zvimwe zvinochengeta. August online urgent care haibvumidzi mishonga yakavhenganiswa kana isiri yakatenderwa neFDA. yeGLP-1 zvigadzirwa.

Mari yemishonga yeGLP-1 inodhura sei mu2026?

Mhinduro ipfupi: zvimwe zvakadhura zvishoma sezvazvaive kare, asi GLP-1 mishonga ichiri kudhura.

Vagadziri vave vachionya zvimwe zvigadzirwa zvevanhu nemitengo yakabudiswa kune zvimwe zvigadzirwa nemimwe mishonga. Zvimwe zvigadzirwa zvemahara mumiriyoni zvakare zvawedzera zvimwe zvakawanda kusarudza pamusika.

Zvaunobhadhara chaizvo zvinoenderana nemushonga, muyero, kuvharwa kweinishuwarenzi, zvimwe zvigadzirwa, uye kana uchikwanisa kune chimwe chipo chevagadziri.

Hezvino mimwe mitengo yakabudiswa yemari chaiyo kune mamwe marudzi emishonga yeGLP-1 mu2026:

Mushonga Fomu Mutengo wakabudiswa wekuzvipa mari
Wegovy 1.5 mg Mahara $149/pamwedzi
Wegovy 4 mg Mahara $199/pamwedzi
Wegovy 9 mg Mahara $299/pamwedzi
Wegovy 25 mg Mahara $299/pamwedzi
Wegovy jekiseni Jekiseni revhiki nevhiki $349/pamwedzi mutengo wakajairika wekuzvipa mari
Wegovy HD 7.2 mg Jekiseni revhiki nevhiki $399/pamwedzi
Foundayo Mahara ezuva nezuva Kutanga pa $149/pamwedzi kune dzimwe mishonga yekuzvipa mari

Aya ndiwo mitengo nemipiro yakabudiswa nevagadziri, kwete kuti zvose varwere vachabhadhara zvakadaro. Zvimwe zvinodiwa kuti uwane, muyero, chimiro cheinishuwarenzi, zvimwe zvigadzirwa, mitero, uye zvigadzirwa zvechipatara zvinogona kuchinja mutengo wekupedzisira.

Mari yemahare eWegovy vs. mari yejekiseni mu2026

Mari yemahare eWegovy ndiyo imwe yeakanyanya kuchinja kwemitengo yekutarisa muna 2026. Chirongwa chekuzvipa mari chemhando yeNovo Nordisk chinopa mitengo yakasiyana zvichienderana nemuyero wehama.

Mitengo yemahare eWegovy yakabudiswa parizvino iri:

Muyero wehama Mutengo wekuzvipa mari
1.5 mg kamwe pazuva $149/pamwedzi
4 mg kamwe pazuva $199/pamwedzi
9 mg kamwe pazuva $299/pamwedzi
25 mg kamwe pazuva $299/pamwedzi

1.5 mg amai ndiyo yekutanga muyero. Mahara eWegovy anowedzera panguva, uye muyero unokurudzirwa neFDA wekuchengetedza uremu muvakuru ndeye 25 mg kamwe pazuva. Zvinoreva kuti mutengo wekutanga we $149 haufanire kuonekwa semutengo unoramba uchibhadharwa nevanhu vose vanotora amai.

Jekiseni rine chimiro chakasiyana chemitengo. Vatsva vanopinda vanokwanisa parizvino kubhadhara $199 pamwedzi kwekutanga kwavo kaviri kwemwedzi mishanu ye0.25 mg kana 0.5 mg kusvika Zvita 31, 2026. Mutengo wekuzvipa mari wakajairika i $349 pamwedzi kune mishonga yakanyorwa yekubaya Wegovy, nepo Wegovy HD 7.2 mg i $399 pamwedzi.

Saka paunenge uchienzanisa mari yemahare eWegovy nemari yejekiseni, usaenzanise mutengo wekutanga we $149 nemutengo wejekiseni we $349 uye kufunga kuti ndiyo ichava mari yako yechinguva refu. Muyero, danho rekutora, uye kugona kune zvipo zvepanguva pfupi zvose zvine basa.

Kuti uwane zvimwe zvakakwana zvekienzaniso chemahara uye jekiseni zvingasarudzwa, ona gwara redu pa GLP-1 mahara vs jekiseni: mutengo, mibairo, uye zvinhu zvakasiyana.

Nei mitengo yeGLP-1 ichichinja mu2026?

Hapana chikonzero chimwe chete chekuti mitengo yeGLP-1 ichichinja. Zvinhu zvakasiyana-siyana zviri kuitika panguva imwe chete.

Kusangana kwakawanda

Wegovy naZepbound havazisisiri zvinhu zvakakura chete zvekugadzirisa uremu. Zvimwe zvigadzirwa zvemahara mumiriyoni zvakadai seFoundayo nemahare eWegovy zvawedzera zvimwe zvakawanda zvingasarudzwa, zvichipa vagadziri nzira imwe yekuita mukwikwidzana kune varwere vanobhadhara mari pachavo.

Zvirongwa zvechipatara zvevanhu zvakazvitsaurira

Novo Nordisk naEli Lilly vakaitora zvimwe zvigadzirwa zvevagadziri zvekuzvipa mari pachavo zvinobudisa mitengo yakadaro yemari chaiyo kune vanopinda vanokwanisa. Zvimwe zvigadzirwa izvi zvinopa varwere nzira imwe yekuwanisa mimwe mishonga kunze kwebhenefiti yavo yeinishuwarenzi.

Zvimwe zvigadzirwa zvemahara mumiriyoni

Mishonga yeGLP-1 yemumiriyoni yakawedzera imwe chikamu chemusika. Foundayo nemahare eWegovy zvinopa varwere zvingasarudzwa kunze kwejekiseni revhiki nevhiki, nemitengo yakabudiswa nevagadziri yemari chaiyo inosiyana nemuyero.

Shanduko mukuvharwa nekwanisiro

Kuvharwa kune zvakare kuchinja mune zvimwe zvigadzirwa. Medicare GLP-1 Bridge yakatanga Chikunguru 1, 2026, uye inovapa Medicare Part D vanobatsirwa mukana wekuwana mimwe mishonga yeGLP-1 yekuderedza muviri pa $50 pamwedzi kune chikamu chekubhadhara. Chirongwa ichi chinoshanda kunze kweMedicare Part D inowanikwa zvakajairika uye chinomhanya kusvika Zvita 31, 2027.

Zvinoreva kuti kwete mushonga weGLP-1 wose wakadhura kana wakavharirwa neinishuwarenzi yose. Zvinoreva kuti vamwe varwere vave nemimwe mikana yekuwana mimwe mishonga nemutengo wakaderera wekuzvipa mari.

Kuvharwa kweMedicare kweGLP-1 mu2026

Kwanisiro yeMedicare kumishonga yeGLP-1 yakachinja mu2026 nekutanga kweMedicare GLP-1 Bridge.

Medicare GLP-1 Bridge

Kutanga Chikunguru 1, 2026, CMS yakatanga Medicare GLP-1 Bridge, chirongwa chepfupi chinoitwa kusvika Zvita 31, 2027. Medicare Part D vanobatsirwa vanokwanisa kuwana mimwe mishonga yeGLP-1 yekuderedza muviri nemutengo we $50 pamwedzi kune chikamu chekubhadhara. Chirongwa ichi chinoshanda kunze kwezvinowanikwa nekutora kweMedicare Part D yakajairika. CMS inotsanangura chirongwa nezvinodiwa zvekugona kune.

Zvigadzirwa zvakakodzera zvino zvinosanganisira Foundayo, jekiseni nemahare eWegovy, uye KwikPen formulation yeZepbound apo inoshandiswa kuderedza uremu hwakawandisa kana kuchengetedza kuderedza uremu.

Kugona nezvinodiwa zvekutanga zvekutendwa zvinoshanda. CMS parizvino inoda kuti vanobatsirwa vawane zvinodiwa zvakatarwa zvehutano, zvinosanganisira zera, BMI, uye mimwe mamiriro ehutano, panguva iyo kurapwa kweGLP-1 kwakatanga.

Chikamu chekubhadhara che $50 chinobata kunze kwezvinowanikwa zveMedicare Part D yakajairika. Kuderera kwePart D hakushandi, uye chikamu chekubhadhara che $50 hachiverengwe kuTrOOP.

Kuvharwa kweMedicare kweimwe nzvimbo

Kunze kweGLP-1 Bridge, kuvharwa kweMedicare kunoenderana nechinangwa chakabvumirwa chemushonga uye bhenefiti reMedicare rinoshanda. Mimwe mishonga yeGLP-1 inovharirwa kuburikidza nePart D apo inopiwa kune zvigadzirwa zvakavharirwa sezvirwere zvedebetei mhando ye2. Wegovy zvakare ine chinangwa chakabvumirwa neFDA chekuderedza njodzi yemamwe zviitiko zvepfungwa muvakuru vane chirwere chemoyo chakatarwa uye vakawandisa kana vakaonda.

Kana uri paMedicare uye uchifunga nezveGLP-1, tarisa kuti nzira yekuvharwa ipi inoshanda kune mushonga wako uye kana uchisangana nezvinodiwa zvekugona kwechirongwa.

Kuvharwa kweInishuwarenzi kweGLP-1s

Kuvharwa kweinishuwarenzi yakazvitsaurira kuchiri kusiyana zvakanyanya.

Zvirongwa zvevashandirwi

Kuvharwa kunoenderana nechirongwa chakasarudzwa. Mimwe mishonga yevashandirwi inovhara GLP-1s yekuderedza muviri, nepo vamwe vachisanganisira mishonga yekuderedza uremu. Kutanga kutendwa kunogona zvakare kudiwa.

Zvirongwa zvepamwechete nezvakachengeterwa

Kuvharwa kunogona kusiyana neinishuwarenzi, nyika, nechirongwa. Mushonga uri wakabvumirwa neFDA yekuderedza muviri haureve kuti chirongwa chechikwata chega chega chichazvidzivirira.

Kutanga kutendwa

Kunyangwe kuvharwa kukuveko, inishuwarenzi inogona kuda kutanga kutendwa. Zvinodiwa zvinogona kusanganisira BMI yakatarwa, mimwe mamiriro ehutano, kuratidzwa kwemiedzo yakambotaurwa yekurapa, kana zvimwe zvinodiwa zvakatevedzwa nechirongwa.

Step therapy

Mimwe mishonga inoda kuti nhengo dziedze mimwe mishonga yekurapa isati yavhura GLP-1. Zvinodiwa izvi zvinosiyana neinishuwarenzi nechirongwa.

Kana chirongwa chako chichivharira GLP-1, chirongwa chekuchengetedza mari chevagadziri chinogona kuderedza mari yako yekuenda nayo kana uchikwanisa. Somuenzaniso, NovoCare parizvino inozivisa kuchengetedza kweinishuwarenzi yemhando ye $25 pamwedzi kune vanopinda vanokwanisa. Vanobatsirwa nehurumende vanosara kubva muchipo ichocho chakasarudzwa.

Semaglutide yakavhenganiswa yakachengeteka here uye yakadhura?

Semaglutide yakavhenganiswa inogona kunge isingadhuri pane zvimwe zvigadzirwa zvakakurumbira, izvo zviri chimwe chikonzero vanhu vanozvitsvaga. Asi mutengo chete haukuzivise kana mushonga wakavhenganiswa wakakodzera kwauri.

Semaglutide yakavhenganiswa haina kufanana neWegovy yakabvumirwa neFDA kana zvimwe zvigadzirwa zvesemaglutide zvakatenderwa neFDA. Mishonga yakavhenganiswa haipinde mukati mekuongorora kwepri-market kweFDA kwechengetedzo, kushanda, uye kunaka kuti mishonga yakabvumirwa yapfuura.

FDA yave ichitaura nezve pamusoro pezvimwe zvigadzirwa zveGLP-1 zvakavhenganiswa, zvinosanganisira:

  • Zvikanganiso zvemuyero zvinosanganisira semaglutide yakavhenganiswa yekubaya
  • Zvisingafadzi, zvinosanganisira mishumo ine zvipatara
  • Zvigadzirwa zvekunyepedzera zvine ruzivo rwechipatara rwenhema
  • Zvinofungidzirwa nezvemamwe mafomu esalutide semaglutide ari kushandiswa muzvigadzirwa
  • Zvigadzirwa zvinotengeswa pasina marejista akakodzera kana kuburikidza nezvakanaka zvisingatarisirwi

Kubva paMay 31, 2026, FDA yakagamuchira mishumo ye1.990 yezviitiko zvisingafadzi zvine chekuita nesemaglutide yakavhenganiswa. Sangano rinoti zviitiko zvisingafadzi zvinogona kunge zviri pasi pekuzivisa uye kuti mushumo wechiitiko chisina kufadza haureve kuti mushonga wakaunza chiitiko ichocho.

Mishonga yakavhenganiswa inogona kugadzirwa zviri pamutemo pasi pezvimwe zvigadzirwa. FDA kazhinji inopa zano kuti mishonga yakavhenganiswa inofanira kushandiswa apo zvinodiwa zvekurapa zvevarwere hazvigoni kusanganiswa nemushonga wakabvumirwa neFDA. Varwere vanofunga nezvemishonga yakavhenganiswa vanofanira kukurukura nazvo nachiremba wavo uye kuwana kubva kuchipatara chine rezinesi chakakodzera.

Kana uchifunga nezvesemaglutide yakavhenganiswa nekuda kwemutengo, bvunza chiremba wako nezve zvingasarudzwa zvakatenderwa neFDA nezvimwe zvigadzirwa zvevagadziri zvepanguva ino usati wasarudza kuti ndeupi sarudzo inokodzera mamiriro ako.

Maitiro ekubhadhara zvishoma kune mishonga yeGLP-1

Kana uchibhadhara mari pachako, enzanisa mutengo chaiwo wekurapa panzvimbo yekungotarisa pamutengo wakanyanya wakaziviswa.

Shandisa zvimwe zvigadzirwa zvevagadziri zvevanhu

Zvirongwa zveNovoCare naLilly zvevanhu zvakazvitsaurira zvinobudisa mitengo yemari chaiyo kune vanopinda vanokwanisa. Enzanisa mitengo iyoyo nezvaunobhadhara kuburikidza neinishuwarenzi kana kuchipatara chako.

Tarisa zvimwe zvigadzirwa zvevagadziri zvekuchengetedza

Kana uine inishuwarenzi yemhando yepamusoro, unogona kukwanisa kushandisa chirongwa chekuchengetedza mari chevagadziri. Kugona kunosiyana, uye vanobatsirwa neMedicare neMedicaid kazhinji vanosara kubva kune zvipo zvemakadhi ekuchengetedza.

Tarisa zvimwe zvigadzirwa zvevarwere

Mimwe vagadziri inopa zvimwe zvigadzirwa zvevarwere kune vanhu vanosangana nezvinodiwa zvakasarudzwa nezvemari. Tarisa nguva dzazvino dzechirongwa zvakananga nevagadziri.

Tarisa kuvharwa kweMedicaid

Kuvharwa kweMedicaid kunosiyana nedunhu nedunhu uye nechinangwa icho mushonga unopiwa. Tarisa chirongwa cheMedicaid che dunhu rako nechirongwa chako chakasarudzwa panzvimbo yekufungidzira kuti kuvharwa kunowanikwa kana kusaderedzwa.

Enzanisa mutengo wakazara wemwedzi

Usienzanise mishonga zvichibva chete pamutengo wekutanga wakaziviswa. Mutengo wekutanga wakaderera unogona kungoshanda kune dzimwe mishonga kana nhamba shoma dzekupinda. Tarisa mutengo wemuyero waunozorayirwa, pamwe chete nechero yekufambidzana, chipatara, kana mari yeinishuwarenzi.

Nguva dzose Mubvunzo Inobvunzwa

Mari yeWegovy inodhura sei pamwedzi mu2026?

Mari yemahare eWegovy i $149 pamwedzi kune 1.5 mg, $199 kune 4 mg, uye $299 kune 9 mg ne25 mg. Kune jekiseni reWegovy, vanopinda vatsva vanokwanisa parizvino kubhadhara $199 pamwedzi kwekutanga kwavo kaviri kwemwedzi mishanu ye0.25 mg kana 0.5 mg kusvika Zvita 31, 2026. Mutengo wekuzvipa mari wakajairika i $349 pamwedzi kune mishonga yakanyorwa yekubaya, nepo Wegovy HD i $399 pamwedzi.

Medicare inovharira Wegovy yekuderedza uremu here?

Mu2026, Medicare Part D vanobatsirwa vanokwanisa kuwana Wegovy nemimwe mishonga yeGLP-1 yekuderedza muviri kuburikidza neMedicare GLP-1 Bridge. Chirongwa chakanga chakatanga Chikunguru 1, 2026, chinomhanya kusvika Zvita 31, 2027, uye chine chikamu chekubhadhara che $50 pamwedzi kune vanobatsirwa vanokwanisa. Kugona nezvinodiwa zvekutanga zvekutendwa zvinoshanda.

Semaglutide yakavhenganiswa yakabvumirwa neFDA here?

Kwete. Semaglutide yakavhenganiswa haina kubvumirwa neFDA. FDA yave ichitaura nezve zvimwe zvigadzirwa zveGLP-1 zvakavhenganiswa, zvinosanganisira zvikanganiso zvemuyero, zvigadzirwa zvekunyepedzera, nezvinetso zvekunaka.

Mari yeFoundayo inodhura sei?

Mari yeFoundayo yekuzvipa mari inotanga pa $149 pamwedzi kune dzimwe mishonga. Mishonga yakasara ine mitengo yakakwirira yakabudiswa, uye mimwe mishonga inogona kuve nemitengo yekusimudzira. Kugona nezvinorambidzwa zvechirongwa zvinoshanda.

Ndinogona kushandisa inishuwarenzi nekadhi rekuchengetedza mari kubva kumugadziri pamwe chete?

Kana uine inishuwarenzi yemhando yepamusoro, unogona kushandisa chirongwa chekuchengetedza mari chevagadziri mushure mekunyoreswa kweinishuwarenzi yako, zvichienderana nechirongwa chakasarudzwa. Vanobatsirwa nehurumende kazhinji vanosara kubva kune zvipo zvekuchengetedza mari. Tarisa nguva dzazvino dzemushonga waunorayirwa.

Mitengo yeGLP-1 icharamba ichidonha here?

Mitengo yeramangwana haina kuvimbiswa. Kukwikwidzana, zvimwe zvigadzirwa, zvimwe zvigadzirwa zvevagadziri zvevanhu, shanduko mukuvharwa kweinishuwarenzi, uye zvingava zvekupedzisira zvinogona kuchinja zvinhu zvinobhadharwa nevarwere. Kana uchienzanisa mitengo, tarisa nguva dzazvino dzemugadziri neinishuwarenzi panzvimbo yekuvimba nemutengo wekare wemari chaiyo.

Mhedziso

Mitengo yeGLP-1 yakachinja mu2026, kunyanya kune vanhu vanokwanisa kune zvimwe zvigadzirwa zvevagadziri zvevanhu. Mahara eWegovy anotanga pa $149 pamwedzi, Foundayo ine mari yekuzvipa mari inotanga pa $149 kune dzimwe mishonga, uye vanopinda vatsva vanokwanisa vejekiseni reWegovy vanogona parizvino kubhadhara $199 kwekutanga kwavo kaviri kwemwedzi mishanu yeimwe mishonga yekutanga.

Kwanisiro yeMedicare zvakare yakachinja. Medicare GLP-1 Bridge inovapa Part D vanobatsirwa vanokwanisa mukana wekuwana mimwe mishonga yeGLP-1 yekuderedza muviri nemutengo we $50 pamwedzi kusvika Zvita 31, 2027.

Inishuwarenzi yakazvitsaurira ichiri kunyanya kusiyana. Kutanga kutendwa, kusabatsirwa kwechirongwa, kuderera, uye kugona kwechirongwa chekuchengetedza mari zvinogona kuchinja mutengo wako wekupedzisira.

Semaglutide yakavhenganiswa inogona kunge iine mutengo wakaderera wakaziviswa, asi haina kubvumirwa neFDA, uye FDA yave ichitaura nezve zvikanganiso zvemuyero, zvigadzirwa zvekunyepedzera, nezvinetso zvekunaka zvine chekuita nezvimwe zvigadzirwa zveGLP-1 zvakavhenganiswa.

Kana uchifunga nezveGLP-1, enzanisa mutengo chaiwo wemuyero waunorayirwa panzvimbo pemutengo wakanyanya wakaziviswa. Bvunza chiremba wako neinishuwarenzi nezve kuvharwa, zvimwe zvigadzirwa zvevagadziri, uye mutengo wakazara wemwedzi usati wasarudza kuti ndeupi sarudzo inokodzera mamiriro ako.